Cholesterol esterification within plasma lipoprotein particles is catalyzed by lecithin:cholesterol acyltransferase (LCAT). The impact of the overexpression of this enzyme on plasma concentrations of the different plasma lipoproteins in an animal model expressing cholesteryl ester transfer protein was evaluated by generating rabbits expressing human LCAT. A 6.2-kilobase human genomic DNA construct was injected into the pronuclei of rabbit embryos. Of the 1002 embryos that were injected, 3 founder rabbits were characterized that expressed the human LCAT gene. As in mice and humans, the principal sites of mRNA expression in these rabbits is in the liver and brain, indicating that the regulatory elements required for tissue-specific expression among these species are similar. The -LCAT activity correlated with the number of copies of LCAT that integrated into the rabbit DNA. Compared with controls, the high expressor LCAT-transgenic rabbits total and high density lipoprotein (HDL) cholesterol concentrations were increased 1.5-2.5-fold with a 3.1-fold increase in the plasma cholesterol esterification rate. Analysis of the plasma lipoproteins by fast protein liquid chromatography indicates that these changes reflected an increased concentration of apolipoprotein E-enriched, HDL-sized particles, whereas atherogenic apolipoprotein B particles disappeared from the plasma. The concentrations of plasma HDL cholesterol were highly correlated with both human LCAT mass (r = 0.93; p = 0.001) and the log LCAT activity (r = 0.94; p < 0.001) in the transgenic rabbits. These results indicate that overexpression of LCAT in the presence of cholesteryl ester transfer protein leads to both hyperalpha-lipoproteinemia and reduced concentrations of atherogenic lipoproteins.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. Cuchel and D. J. Rader Macrophage Reverse Cholesterol Transport: Key to the Regression of Atherosclerosis? Circulation, May 30, 2006; 113(21): 2548 - 2555. [Full Text] [PDF]

				J. F. P. Berbee, C. C. van der Hoogt, D. Sundararaman, L. M. Havekes, and P. C. N. Rensen Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL J. Lipid Res., February 1, 2005; 46(2): 297 - 306. [Abstract] [Full Text] [PDF]

				C.C. Shoulders, E.L. Jones, and R.P. Naoumova Genetics of familial combined hyperlipidemia and risk of coronary heart disease Hum. Mol. Genet., April 1, 2004; 13(90001): R149 - 160. [Abstract] [Full Text] [PDF]

				D. S. Ng, C. Xie, G. F. Maguire, X. Zhu, F. Ugwu, E. Lam, and P. W. Connelly Hypertriglyceridemia in Lecithin-cholesterol Acyltransferase-deficient Mice Is Associated with Hepatic Overproduction of Triglycerides, Increased Lipogenesis, and Improved Glucose Tolerance J. Biol. Chem., February 27, 2004; 279(9): 7636 - 7642. [Abstract] [Full Text] [PDF]

				K. L. Herron, S. Vega-Lopez, K. Conde, T. Ramjiganesh, S. Roy, N. S. Shachter, and M. L. Fernandez Pre-Menopausal Women, Classified as Hypo- or Hyper-Responders, do not Alter their LDL/HDL Ratio Following a High Dietary Cholesterol Challenge J. Am. Coll. Nutr., June 1, 2002; 21(3): 250 - 258. [Abstract] [Full Text] [PDF]

				A. D. Attie, J. P. Kastelein, and M. R. Hayden Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis J. Lipid Res., November 1, 2001; 42(11): 1717 - 1726. [Abstract] [Full Text] [PDF]

				L. Zhou and A. Nilsson Sources of eicosanoid precursor fatty acid pools in tissues J. Lipid Res., October 1, 2001; 42(10): 1521 - 1542. [Abstract] [Full Text] [PDF]

				M. E. Brousseau, R. D. Kauffman, E. E. Herderick, S. J. Demosky Jr, W. Evans, S. Marcovina, S. Santamarina-Fojo, H. B. Brewer Jr, and J. M. Hoeg LCAT Modulates Atherogenic Plasma Lipoproteins and the Extent of Atherosclerosis Only in the Presence of Normal LDL Receptors in Transgenic Rabbits Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 450 - 458. [Abstract] [Full Text] [PDF]

				P. Holvoet, B. De Geest, S. Van Linthout, M. Lox, S. Danloy, K. Raes, and D. Collen The Arg123-Tyr166 Central Domain of Human ApoAI Is Critical for Lecithin:Cholesterol Acyltransferase-Induced Hyperalphalipoproteinemia and HDL Remodeling in Transgenic Mice Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 459 - 466. [Abstract] [Full Text] [PDF]

				B. Foger, M. Chase, M. J. Amar, B. L. Vaisman, R. D. Shamburek, B. Paigen, J. Fruchart-Najib, J. A. Paiz, C. A. Koch, R. F. Hoyt, et al. Cholesteryl Ester Transfer Protein Corrects Dysfunctional High Density Lipoproteins and Reduces Aortic Atherosclerosis in Lecithin Cholesterol Acyltransferase Transgenic Mice J. Biol. Chem., December 24, 1999; 274(52): 36912 - 36920. [Abstract] [Full Text] [PDF]

				R. K. Tangirala, K. Tsukamoto, S. H. Chun, D. Usher, E. Pure, and D. J. Rader Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in Mice Circulation, October 26, 1999; 100(17): 1816 - 1822. [Abstract] [Full Text] [PDF]

				M. E. Brousseau and J. M. Hoeg Transgenic rabbits as models for atherosclerosis research J. Lipid Res., March 1, 1999; 40(3): 365 - 375. [Abstract] [Full Text]

				M. E. Brousseau, J. Wang, S. J. Demosky , Jr., B. L. Vaisman, G. D. Talley, S. Santamarina-Fojo, H. B. Brewer , Jr., and J. M. Hoeg Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase J. Lipid Res., August 1, 1998; 39(8): 1558 - 1567. [Abstract] [Full Text]

				K. L. Hoppe and O. L. Francone Binding and functional effects of transcription factors Sp1 and Sp3 on the proximal human lecithin:cholesterol acyltransferase promoter J. Lipid Res., May 1, 1998; 39(5): 969 - 977. [Abstract] [Full Text]

				M. Liu, R. W. St. Clair, and P. V. Subbaiah Impaired function of lecithin:cholesterol acyltransferase in atherosclerosis-susceptible White Carneau pigeons: possible effects on metabolism of oxidized phospholipids J. Lipid Res., February 1, 1998; 39(2): 245 - 254. [Abstract] [Full Text]

				M. K. Hong, J. Vossoughi, G. S. Mintz, R. D. Kauffman, R. F. Hoyt Jr, J. F. Cornhill, E. E. Herderick, M. B. Leon, and J. M. Hoeg Altered Compliance and Residual Strain Precede Angiographically Detectable Early Atherosclerosis in Low-Density Lipoprotein Receptor Deficiency Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2209 - 2217. [Abstract] [Full Text]

				Y. Huang, S. W. Schwendner, S. C. Rall Jr., D. A. Sanan, and R. W. Mahley Apolipoprotein E2 Transgenic Rabbits. MODULATION OF THE TYPE III HYPERLIPOPROTEINEMIC PHENOTYPE BY ESTROGEN AND OCCURRENCE OF SPONTANEOUS ATHEROSCLEROSIS J. Biol. Chem., September 5, 1997; 272(36): 22685 - 22694. [Abstract] [Full Text] [PDF]

				N. Sakai, B. L. Vaisman, C. A. Koch, R. F. Hoyt Jr., S. M. Meyn, G. D. Talley, J. A. Paiz, H. B. Brewer Jr., and S. Santamarina-Fojo Targeted Disruption of the Mouse Lecithin:Cholesterol Acyltransferase (LCAT) Gene. GENERATION OF A NEW ANIMAL MODEL FOR HUMAN LCAT DEFICIENCY J. Biol. Chem., March 14, 1997; 272(11): 7506 - 7510. [Abstract] [Full Text] [PDF]

				G. Lambert, N. Sakai, B. L. Vaisman, E. B. Neufeld, B. Marteyn, C.-C. Chan, B. Paigen, E. Lupia, A. Thomas, L. J. Striker, et al. Analysis of Glomerulosclerosis and Atherosclerosis in Lecithin Cholesterol Acyltransferase-deficient Mice J. Biol. Chem., April 27, 2001; 276(18): 15090 - 15098. [Abstract] [Full Text] [PDF]